Notícias

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.

Micron has been one of the most volatile stocks in the AI trade all year. Something Citi published on September 23 changes how that volatility reads.

Mondi’s updated fair value estimate has shifted from £8.45 to £8.86, which gives you a fresh reference point for thinking about the stock’s longer term price target. Recent research shows some analysts lifting targets toward 1,040 GBp while others move to more cautious levels such as 840 GBp and 750 GBp, so the gap between optimistic and neutral views is clear. In the sections that follow, you will see how these changing targets, and the news around Mondi, can help you track the evolving...

JPM is exploring a private-credit "second-look" model that could widen card approvals while limiting exposure to higher-risk borrowers.

Citigroup wants clients to park more of their cash and investments with the bank. It’s offering incentives to make it happen.

Citigroup has delivered very strong gains over the past few years, and that kind of run naturally raises a harder question for you as a shareholder. Is the current price really supported by the returns the bank earns on the capital it puts to work? Over the past 3 years the stock has returned about 2.6x, which puts real pressure on the investment case to be backed by sustained returns on capital rather than just a rerating story. The launch of Citi Commerce Media, along with moves into areas...

Pricing strength is reshaping Micron's near-term earnings outlook

A massive infrastructure push is reshaping Alibaba's growth story

Alibaba's AI Ambitions Trigger Massive Spending Forecast From Citi

Micron Stock in Focus as Citi Lifts Forecasts on Hotter Memory Pricing

The New York Stock Exchange (NYSE) and crypto platform Blockchain.com have...

Edgewater analyst Joe Wittine expects fourth-quarter revenue growth of 8% to 9% sequentially following fresh channel checks.

Investing.com -- Citi expects Micron shares to rally into the SEMICON West conference, raising its price target on the memory maker to $1,300 from $1,150.

GS is in talks to acquire Palmer Square, potentially boosting its credit capabilities, AWM franchise and recurring fee revenues.

Micron stock is surging ahead of its earnings but Citi analyst Atif Malik has a warning about memory-chip prices.

Equity analysts have turned net negative on the outlook for US corporate earnings for the first time in months, reflecting concerns about the effect on profits of inflation and higher interest rates.

The Thornburg Investment Income Builder fund’s “nerdy” investment strategy has delivered a one-year return of 29%.

In a trial in patients with Sjögren’s disease, Amgen’s dazodalibep produced a statistically significant and clinically meaningful improvement on a standard score of how the disease affects organs and systems.

Wall Street analysts are generally a conservative bunch. They rarely model a company tripling its top line, because most companies don’t.

JPM could see a modest NII rise from the Fed's 25-basis-point rate hike, though deposit costs, loan demand and credit quality remain key variables.

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

In the latest trading session, Citigroup (C) closed at $135.06, marking a +2.5% move from the previous day.

Investing.com -- In a note on Monday, Citi flagged two key memory names as beneficiaries of a sharp rise in demand for enterprise solid-state drives, driven by artificial intelligence.

Investing.com -- In a note on Monday, Citi flagged three Chinese component makers as beneficiaries of a sharp ramp-up in humanoid robot production, citing supply chain checks in China.

BRP now carries a higher Fair Value Estimate of CA$103.07, up from CA$97.22, which lines up more closely with the Street price targets that have been cited after the latest update. Recent analyst commentary reflects this shift, with more upbeat views tying higher targets to Q2 execution and product momentum, while cautious voices still highlight tariff and valuation risks. As you read on, you will see how this evolving narrative around BRP may shape the way you track the stock from here. Stay...

Citi expects shortages across the global memory semiconductor market to deepen through 2031, driven by increasing demand for high-bandwidth memory (HBM), DRAM and NAND as artificial intelligence systems adopt continual learning. In a research note published Monday, the investment bank identified continual learning as a potential central theme in AI development over the next five years.

Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...

The JPMorgan Chase CEO’s career comeback is one for the books.

Jefferies Financial (JEF) is poised to benefit from increased investment banking momentum in the thi

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Citigroup (C) have what it takes? Let's find out.